Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma.
By F. Denis, P. Garaud, É. Bardet, M. Alfonsi, C. Sire, T. Germain, P. Bergerot, B. Rhein, J. Tortochaux, G. Calais. Journal of Clinical Oncology, 2004
880 citations recorded by the source corpus.
Subfields: Otorhinolaryngology, Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/479212e38f8e691c7921b20d2570b9c616916731
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Otorhinolaryngology
In Surgery
Citations in the corpus
- Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. (2016, background): “For locally advanced OPSCC, chemoradiation compared with radiation alone has documented significant improvement in overall survival, locoregional control, and disease-free survival.(41,42) Chemoradiation is considered the standard of care for locally advanced OPSCC.”
- Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond (2005, background): “Oropharyngeal cancer has notably become less of a surgical disease over the last five years, as cure rates with organ preservation therapy are widely recognized to equal those achieved with surgery followed by postoperative radiation therapy.(72,73) Preliminary, single-institution results of IMRT in”